By Houman Tamaddon : Editors' Note: This article covers a stock trading at less than $1 per share and/or with less than a $100 million market cap. Please be aware of the risks associated with these stocks. Suppose a very wise and analytical investor makes the following argument: 1) The U.S. ...
By Valuable Insights : This is the eleventh piece in Seeking Alpha's Positioning for 2014 series. This year we have once again asked experts on a range of different asset classes and investing strategies to offer their vision for the coming year and beyond. As always, the focus is on an overall ...
Scientific Officer Jon Isaacsohn - Chief Medical Officer Elisabeth Kogan - Head of Generic R&D Mary Ogle - Vice President of NTE Commercial Jim Ottinger - Regulatory Sharon Hausdorff - Intellectual Property and Legal Analysts Liav Abraham - Citi Jason Gerberry
we continue to view Teva's first-to-file opportunities as the best among peers (blue bar below). (click to enlarge) Source: Actavis, Valuentum (January 2013) Our Take Teva's huge opportunity remains in its NTE Complete Story »
We're lowering Nam Tai Electronics ' NTE fair value estimate to $19 per share from $23. This reflects the firm's focus on manufacturing higher-volume, lower-margin
By John Rolfe : Nam Tai Electronics , Inc. ( NTE ) ("Nam Tai" or the "Company") is an electronic manufacturing services ("EMS") provider. The Company currently trades
NEW YORK, Nov 5 (Reuters) - Nam Tai Electronics Inc : * Jumps 19.5 percent premarket after Q3 results
We are no longer providing equity research on Nam Tai Electronics NTE . We provide broad coverage of more than 1,800 companies across 91 industry groups and adjust our coverage as necessary based on client demand and investor interest.
Nam Tai Electronics NTE is slated to release first-quarter earnings Monday, and we expect it will show continued poor results. In his May 4 letter
Nam Tai Electronics NTE reported earnings Feb.9, and we are lowering our fair value estimate based on our belief that the company's high exposure